Diabetic nephropathy is a leading cause of end stage renal disease and its occurance is increasing worldwide. The most effective treatment strategy for the condition is intensive treatment to strictly control glycemia and blood pressure using renin-angiotensin system inhibitors. However, a fraction of patients still go on to reach end stage renal disease even under such intensive care. New therapeutic targets for diabetic nephropathy are, therefore, urgently needed. Autophagy is a major catabolic pathway by which mammalian cells degrade macromolecules and organelles to maintain intracellular homeostasis. The accumulation of damaged proteins and organelles is associated with the pathogenesis of diabetic nephropathy. Autophagy in the kidney is activated under some stress conditions, such as oxidative stress and hypoxia in proximal tubular cells, and occurs even under normal conditions in podocytes. These and other accumulating findings have led to a hypothesis that autophagy is involved in the pathogenesis of diabetic nephropathy. Here, we review recent findings underpinning this hypothesis and discuss the advantages of targeting autophagy for the treatment of diabetic nephropathy.

Citations

Citations to this article as recorded by  

• Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications
  Yi Chen, Yashpal S. Kanwar, Xueqin Chen, Ming Zhan
  Current Medicinal Chemistry.2024; 31(6): 697.     CrossRef
• Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
  Xudong Zhuang, Zhuye Sun, Huasheng Du, Tianhui Zhou, Jing Zou, Wei Fu
  Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
• Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway
  Honghong Liu, Jiao Wang, Guanru Yue, Jixiong Xu
  Renal Failure.2024;[Epub]     CrossRef
• Epigenetic Regulation of Autophagy in Bone Metabolism
  Yazhou Zhang, Qianqian Wang, Hongjia Xue, Yujin Guo, Shanshan Wei, Fengfeng Li, Linqiang Gong, Weiliang Pan, Pei Jiang
  Function.2024;[Epub]     CrossRef
• The interaction between lncRNAs and transcription factors regulating autophagy in human cancers: A comprehensive and therapeutical survey
  Saade Abdalkareem Jasim, Yasir Qasim Almajidi, Reyadh R. Al‐Rashidi, Ahmed Hjazi, Irfan Ahmad, Ahmed Hussien Radie Alawadi, Enas R. Alwaily, Hashem O. Alsaab, Ali Haslany, Mohamood Hameed
  Cell Biochemistry and Function.2024;[Epub]     CrossRef
• The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
  Yiwei Gao, Xin Su, Taiqi Xue, Ning Zhang
  Biomedicine & Pharmacotherapy.2023; 163: 114598.     CrossRef
• #2601 THE MOLECULAR EFFECT OF SGLT2I ON THE AUTOPHAGY PATHWAY IN TYPE II DIABETES MELLITUS AND ITS VASCULAR COMPLICATIONS
  Offir Ertracht, Raneen Saad, Hagar Tadmor, Farid Nakhoul, Nakhoul Nakhoul
  Nephrology Dialysis Transplantation.2023;[Epub]     CrossRef
• Role of oxidative stress in diabetes-induced complications and their management with antioxidants
  Hasandeep Singh, Rajanpreet Singh, Arshdeep Singh, Harshbir Singh, Gurpreet Singh, Sarabjit Kaur, Balbir Singh
  Archives of Physiology and Biochemistry.2023; : 1.     CrossRef
• Stress can affect mitochondrial energy metabolism and AMPK/SIRT1 signaling pathway in rats
  An-ran Zhao, Jie Li, Si-qi Wang, Li-hua Bian, Wen-jing Li, Jian-you Guo
  Brain Research Bulletin.2023; 203: 110770.     CrossRef
• Emerging links between FOXOs and diabetic complications
  Urvi M. Parmar, Manjiri P. Jalgaonkar, Aayush J. Kansara, Manisha J. Oza
  European Journal of Pharmacology.2023; 960: 176089.     CrossRef
• Pathophysiology of diabetic kidney disease and autophagy: A review
  Jiawei Yu, Yan Liu, Hongjie Li, Peirong Zhang
  Medicine.2023; 102(30): e33965.     CrossRef
• Microcystin-LR-induced autophagy via miR-282–5p/PIK3R1 pathway in Eriocheir sinensis hepatopancreas
  Yuning Zhang, Jiancao Gao, Liping Cao, Jinliang Du, Gangchun Xu, Pao Xu
  Ecotoxicology and Environmental Safety.2023; 267: 115661.     CrossRef
• Global research trends and hot spots on autophagy and kidney diseases: a bibliometric analysis from 2000 to 2022
  Sinan Ai, Yake Li, Huijuan Zheng, Zhen Wang, Weijing Liu, JiaYin Tao, Yaotan Li, Yaoxian Wang
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence
  Yuexin Zhu, Manyu Luo, Xue Bai, Yan Lou, Ping Nie, Shan Jiang, Jicui Li, Bing Li, Ping Luo
  Molecular and Cellular Biochemistry.2022; 477(8): 2073.     CrossRef
• Dictyophora Polysaccharide Attenuates As-Mediated PINK1/Parkin Pathway-Induced Mitophagy in L-02 Cell through Scavenging ROS
  Ting Hu, Ju Lu, Changyan Wu, Tianxiao Duan, Peng Luo
  Molecules.2022; 27(9): 2806.     CrossRef
• Asiatic acid from Cyclocarya paliurus regulates the autophagy–lysosome system via directly inhibiting TGF-β type I receptor and ameliorates diabetic nephropathy fibrosis
  Xuan-xuan Zhang, Yao Liu, Su-su Xu, Ru Yang, Cui-hua Jiang, Li-ping Zhu, Yin-ying Xu, Ke Pan, Jian Zhang, Zhi-qi Yin
  Food & Function.2022; 13(10): 5536.     CrossRef
• Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling
  Marziyeh Salami, Raziyeh Salami, Alireza Mafi, Mohammad-Hossein Aarabi, Omid Vakili, Zatollah Asemi
  Current Molecular Pharmacology.2022; 15(5): 716.     CrossRef
• Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria
  Nasir Shah, Vlado Perkovic, Sradha Kotwal
  Expert Review of Clinical Pharmacology.2022; 15(7): 827.     CrossRef
• Autophagy-nutrient sensing pathways in diabetic complications
  Urvi M. Parmar, Manjiri P. Jalgaonkar, Yogesh A. Kulkarni, Manisha J. Oza
  Pharmacological Research.2022; 184: 106408.     CrossRef
• The Molecular Effects of SGLT2i Empagliflozin on the Autophagy Pathway in Diabetes Mellitus Type 2 and Its Complications
  Ranin Saad, Hagar Tadmor, Offir Ertracht, Nakhoul Nakhoul, Farid Nakhoul, Farber Evgeny, Shaul Atar, Bernd Stratmann
  Journal of Diabetes Research.2022; 2022: 1.     CrossRef
• What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
  Kimio Watanabe, Emiko Sato, Eikan Mishima, Mariko Miyazaki, Tetsuhiro Tanaka
  International Journal of Molecular Sciences.2022; 24(1): 570.     CrossRef
• Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril
  Dalia Kamal Mostafa, Mohamed Mostafa Khedr, Mervat Kamel Barakat, Amany Abdelbary Abdellatif, Amal Mohamed Elsharkawy
  Life Sciences.2021; 265: 118818.     CrossRef
• Epigenetic modulation of autophagy genes linked to diabetic nephropathy by administration of isorhamnetin in Type 2 diabetes mellitus rats
  Marwa Matboli, Doaa Ibrahim, Amany H Hasanin, Mohamed K Hassan, Eman K Habib, Miram M Bekhet, Ahmed M Afifi, Sanaa Eissa
  Epigenomics.2021; 13(3): 187.     CrossRef
• Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy
  Yuxiang Liu, Wenyuan Liu, Ziyuan Zhang, Yaling Hu, Xiaodong Zhang, Yanyan Sun, Qingqing Lei, Dalin Sun, Ting Liu, Yanjun Fan, Hui Li, Wujie Ding, Jingai Fang
  Renal Failure.2021; 43(1): 128.     CrossRef
• Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation
  Theodomir Dusabimana, Eun Jung Park, Jihyun Je, Kyuho Jeong, Seung Pil Yun, Hye Jung Kim, Hwajin Kim, Sang Won Park
  International Journal of Molecular Sciences.2021; 22(4): 1651.     CrossRef
• Update on diagnosis, pathophysiology, and management of diabetic kidney disease
  Mai Sugahara, Wai Lun Will Pak, Tetsuhiro Tanaka, Sydney C. W. Tang, Masaomi Nangaku
  Nephrology.2021; 26(6): 491.     CrossRef
• Life-Long Hyperbilirubinemia Exposure and Bilirubin Priming Prevent In Vitro Metabolic Damage
  Annalisa Bianco, Serena Pinci, Claudio Tiribelli, Cristina Bellarosa
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
  Liang-Jun Yan
  Biomolecules.2021; 11(5): 730.     CrossRef
• Circular RNAs act as regulators of autophagy in cancer
  Zhixia Zhou, Yinfeng Zhang, Jinning Gao, Xiaodan Hao, Chan Shan, Jing Li, Cuiyun Liu, Yin Wang, Peifeng Li
  Molecular Therapy - Oncolytics.2021; 21: 242.     CrossRef
• Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3β signaling pathway
  Xi-zhi Li, Hong Jiang, Liu Xu, Yi-qi Liu, Jia-wei Tang, Jia-sen Shi, Xiu-juan Yu, Xue Wang, Lei Du, Qian Lu, Cheng-lin Li, Yao-wu Liu, Xiao-xing Yin
  Biochemical Pharmacology.2021; 192: 114675.     CrossRef
• Dietary Restriction for Kidney Protection: Decline in Nephroprotective Mechanisms During Aging
  Nadezda V. Andrianova, Marina I. Buyan, Anastasia K. Bolikhova, Dmitry B. Zorov, Egor Y. Plotnikov
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Induction of PDCD4 by albumin in proximal tubule epithelial cells potentiates proteinuria-induced dysfunctional autophagy by negatively targeting Atg5
  Ezra Kombo Osoro, Xiaojuan Du, Dong Liang, Xi Lan, Riaz Farooq, Fumeng Huang, Wenhua Zhu, Jiajun Ren, Muhammad Sadiq, Lifang Tian, Xudong Yang, Dongmin Li, Shemin Lu
  Biochemistry and Cell Biology.2021; 99(5): 617.     CrossRef
• Overexpressing STAMP2 attenuates diabetic renal injuries via upregulating autophagy in diabetic rats
  Fang-qiang Song, Ming Song, Wei-xuan Ma, Zhan Gao, Yun Ti, Xu Zhang, Bo-ang Hu, Ming Zhong, Wei Zhang, Ying Yu
  Biochemical and Biophysical Research Communications.2021; 579: 47.     CrossRef
• Mitochondrial Regulation of Diabetic Kidney Disease
  Daniel L. Galvan, Koki Mise, Farhad R. Danesh
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Diabetic kidney disease update: Pathogenesis and treatment overview for clinicians
  Elmukhtar Habas, Abdel-Naser Elzouki
  Journal of Diabetes and Endocrine Practice.2021; 04(03): 107.     CrossRef
• VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy
  Bin Wang, Jing-yi Qian, Tao-tao Tang, Li-lu Lin, Nan Yu, Hong-lei Guo, Wei-jie Ni, Ling-Li Lv, Yi Wen, Zuo-Lin Li, Min Wu, Jing-Yuan Cao, Bi-Cheng Liu
  Diabetes.2021; 70(11): 2639.     CrossRef
• SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy
  Jing Ji, Pengyu Tao, Qian Wang, Lingxing Li, Yuzhen Xu
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2021; 21(5): 835.     CrossRef
• SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation
  Mingzhu Jiang, Min Zhao, Mi Bai, Juan Lei, Yanggang Yuan, Songming Huang, Yue Zhang, Guixia Ding, Zhanjun Jia, Aihua Zhang
  Kidney Diseases.2021; 7(4): 293.     CrossRef

• Salvianolic Acid B Improves Chronic Mild Stress-Induced Depressive Behaviors in Rats: Involvement of AMPK/SIRT1 Signaling Pathway

  
  Dehua Liao, Yun Chen, Yujin Guo, Changshui Wang, Ni Liu, Qian Gong, Yingzhou Fu, Yilan Fu, Lizhi Cao, Dunwu Yao, Pei Jiang
  Journal of Inflammation Research.2020; Volume 13: 195.     CrossRef
• Long non-coding RNAs and pyroptosis
  Dong He, Jun Zheng, Jia Hu, Juan Chen, Xing Wei
  Clinica Chimica Acta.2020; 504: 201.     CrossRef
• Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy
  Fang Wang, Ran Li, Linlin Zhao, Shuang Ma, Guijun Qin
  European Journal of Pharmacology.2020; 885: 173387.     CrossRef
• Beneficial Effect of Chloroquine and Amodiaquine on Type 1 Diabetic Tubulopathy by Attenuating Mitochondrial Nox4 and Endoplasmic Reticulum Stress
  Jun Mo Kang, Hyun-Seob Lee, Junghyun Kim, Dong Ho Yang, Hye Yun Jeong, Yu Ho Lee, Dong-Jin Kim, Seon Hwa Park, MinJi Sung, Jaehee Kim, Hyun-Ju An, Sang Ho Lee, So-Young Lee
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway
  Shuangli Yang, Chuman Lin, Xiaoyun Zhuo, Jiyu Wang, Shitao Rao, Wen Xu, Yanzhen Cheng, Li Yang
  American Journal of Physiology-Endocrinology and Metabolism.2020; 319(6): E1019.     CrossRef
• Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy
  Xu-shun Jiang, Xing-yang Xiang, Xue-mei Chen, Jun-ling He, Ting Liu, Hua Gan, Xiao-gang Du
  Cell Death & Disease.2020;[Epub]     CrossRef
• Orientin Protects Podocytes from High Glucose Induced Apoptosis through Mitophagy
  Zi‐Li Kong, Kui Che, Jian‐Xia Hu, Ying Chen, Yun‐Yang Wang, Xiang Wang, Wen‐Shan Lü, Yan‐Gang Wang, Jing‐Wei Chi
  Chemistry & Biodiversity.2020;[Epub]     CrossRef
• Sex-Specific Metabolic Changes in Peripheral Organs of Diabetic Mice
  Xi Zhang, Hangying Xu, Jie Ning, Hui Ji, Junjie Yan, Yafei Zheng, Qingqing Xu, Chen Li, Liangcai Zhao, Hong Zheng, Hongchang Gao
  Journal of Proteome Research.2020; 19(8): 3011.     CrossRef
• Liver X receptor activation induces podocyte injury via inhibiting autophagic activity
  Ziyi Zhang, Shengjie Tang, Weiwei Gui, Xihua Lin, Fenping Zheng, Fang Wu, Hong Li
  Journal of Physiology and Biochemistry.2020; 76(2): 317.     CrossRef
• Autophagy plays a protective role duringPseudomonas aeruginosa-induced apoptosis via ROS–MAPK pathway
  Lu Han, Qinmei Ma, Jialin Yu, Zhaoqian Gong, Chenjie Ma, Yanan Xu, Guangcun Deng, Xiaoling Wu
  Innate Immunity.2020; 26(7): 580.     CrossRef
• Autophagy in diabetic nephropathy: a review
  Elias A. T. Koch, Rola Nakhoul, Farid Nakhoul, Nakhoul Nakhoul
  International Urology and Nephrology.2020; 52(9): 1705.     CrossRef
• P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response
  Theodomir Dusabimana, So Ra Kim, Eun Jung Park, Jihyun Je, Kyuho Jeong, Seung Pil Yun, Hye Jung Kim, Hwajin Kim, Sang Won Park
  Molecular Metabolism.2020; 42: 101089.     CrossRef
• Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment via De Novo Sphingolipid Synthesis
  Stefania Lama, Vincenzo Monda, Maria Rosaria Rizzo, Marco Dacrema, Maria Maisto, Giuseppe Annunziata, Gian Carlo Tenore, Ettore Novellino, Paola Stiuso, Laura Sartiani
  Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
• Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy
  Yu Ho Lee, Sang Hoon Kim, Jun Mo Kang, Jin Hyung Heo, Dong-Jin Kim, Seon Hwa Park, MinJi Sung, Jaehee Kim, Jisu Oh, Dong Ho Yang, Sang Ho Lee, So-Young Lee
  American Journal of Physiology-Renal Physiology.2019; 317(4): F767.     CrossRef
• Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy
  Sugandh Saxena, Alpana Mathur, Poonam Kakkar
  Journal of Cellular Physiology.2019; 234(11): 19223.     CrossRef
• High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress
  Yuxue Zhao, Wenting Zhang, Qi Jia, Zhendong Feng, Jing Guo, Xueting Han, Yuning Liu, Hongcai Shang, Yaoxian Wang, Wei Jing Liu
  Frontiers in Physiology.2019;[Epub]     CrossRef
• Caffeic Acid Modulates miR-636 Expression in Diabetic Nephropathy Rats
  Ahmed M. Salem, Aya S. Ragheb, Marwa G. A. Hegazy, Marwa Matboli, Sanaa Eissa
  Indian Journal of Clinical Biochemistry.2019; 34(3): 296.     CrossRef
• Mechanistic Understanding of the Engineered Nanomaterial-Induced Toxicity on Kidney
  Haiyang Zhao, Luxin Li, Huilu Zhan, Yanhui Chu, Bingbing Sun
  Journal of Nanomaterials.2019; 2019: 1.     CrossRef
• Diabetic nephropathy: An update on pathogenesis and drug development
  Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754.     CrossRef
• Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway
  Qian Yu, Minda Zhang, Lifen Qian, Dan Wen, Guanzhong Wu
  Life Sciences.2019; 225: 1.     CrossRef
• Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
  Yan Chen, Qingpu Liu, Zengfu Shan, Wangyang Mi, Yingying Zhao, Meng Li, Baiyan Wang, Xiaoke Zheng, Weisheng Feng
  Frontiers in Pharmacology.2019;[Epub]     CrossRef
• Role of sirtuin-1 in diabetic nephropathy
  Wanning Wang, Weixia Sun, Yanli Cheng, Zhonggao Xu, Lu Cai
  Journal of Molecular Medicine.2019; 97(3): 291.     CrossRef
• Energy restriction in renal protection
  Si-Yang Wang, Guang-Yan Cai, Xiang-Mei Chen
  British Journal of Nutrition.2018; 120(10): 1149.     CrossRef
• The dysregulated autophagy signaling is partially responsible for defective podocyte development in wt1a mutant zebrafish
  Xuemei Zhang, Qiaohong Lin, Fan Ren, Jin Zhang, Farman Ullah Dawar, Jie Mei
  Aquaculture and Fisheries.2018; 3(3): 99.     CrossRef
• Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice
  Hwajin Kim, Theodomir Dusabimana, So Kim, Jihyun Je, Kyuho Jeong, Min Kang, Kye Cho, Hye Kim, Sang Park
  Nutrients.2018; 10(11): 1703.     CrossRef
• Acute Kidney Injury and Progression of Diabetic Kidney Disease
  Samuel Mon-Wei Yu, Joseph V. Bonventre
  Advances in Chronic Kidney Disease.2018; 25(2): 166.     CrossRef
• Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J‐Leprdb mice
  Peter C. Reifsnyder, Sergey Ryzhov, Kevin Flurkey, Rea P. Anunciado‐Koza, Ian Mills, David E. Harrison, Robert A. Koza
  Annals of the New York Academy of Sciences.2018; 1418(1): 106.     CrossRef
• Viability of primary cultured podocytes is associated with extracellular high glucose-dependent autophagy downregulation
  Irena Audzeyenka, Dorota Rogacka, Agnieszka Piwkowska, Stefan Angielski, Maciej Jankowski
  Molecular and Cellular Biochemistry.2017; 430(1-2): 11.     CrossRef
• Autophagy Protects against Palmitic Acid-Induced Apoptosis in Podocytes in vitro
  Xu-shun Jiang, Xue-mei Chen, Jiang-min Wan, Hai-bo Gui, Xiong-zhong Ruan, Xiao-gang Du
  Scientific Reports.2017;[Epub]     CrossRef
• Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes
  Yu Liu, Jia Zhang, Yangjia Wang, Xiangjun Zeng
  Cell Death & Disease.2017; 8(8): e3006.     CrossRef
• Autophagy and its link to type II diabetes mellitus
  Jai-Sing Yang, Chi-Cheng Lu, Sheng-Chu Kuo, Yuan-Man Hsu, Shih-Chang Tsai, Shih-Yin Chen, Yng-Tay Chen, Ying-Ju Lin, Yu-Chuen Huang, Chao-Jung Chen, Wei-De Lin, Wen-Lin Liao, Wei-Yong Lin, Yu-Huei Liu, Jinn-Chyuan Sheu, Fuu-Jen Tsai
  BioMedicine.2017; 7(2): 8.     CrossRef
• Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy
  Shan-Shan Huang, Da-Fa Ding, Sheng Chen, Cheng-Long Dong, Xiao-Long Ye, Yang-Gang Yuan, Ya-Min Feng, Na You, Jia-Rong Xu, Heng Miao, Qiang You, Xiang Lu, Yi-Bing Lu
  Scientific Reports.2017;[Epub]     CrossRef
• Long non-coding RNAs involved in autophagy regulation
  Lixian Yang, Hanying Wang, Qi Shen, Lifeng Feng, Hongchuan Jin
  Cell Death & Disease.2017; 8(10): e3073.     CrossRef
• Treatment of diabetic kidney disease: current and future targets
  Mi-Kyung Kim
  The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef
• MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice
  Yanru Zhao, Zhongwei Yin, Huaping Li, Jiahui Fan, Shenglan Yang, Chen Chen, Dao Wen Wang
  Aging Cell.2017; 16(2): 387.     CrossRef

Diabetic neuropathy is one of the major complications of diabetes, and it increases morbidity and mortality in patients with both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Because the autonomic nervous system, for example, parasympathetic axons, has a diffuse and wide distribution, we do not know the morphological changes that occur in autonomic neural control and their exact mechanisms in diabetic patients with diabetic autonomic neuropathy (DAN). Although the prevalence of sympathetic and parasympathetic neuropathy is similar in T1DM versus T2DM patients, sympathetic nerve function correlates with parasympathetic neuropathy only in T1DM patients. The explanation for these discrepancies might be that parasympathetic nerve function was more severely affected among T2DM patients. As parasympathetic nerve damage seems to be more advanced than sympathetic nerve damage, it might be that parasympathetic neuropathy precedes sympathetic neuropathy in T2DM, which was Ewing's concept. This could be explained by the intrinsic morphologic difference. Therefore, the morphological changes in the sympathetic and parasympathetic nerves of involved organs in T1DM and T2DM patients who have DAN should be evaluated. In this review, evaluation methods for morphological changes in the epidermal nerves of skin, and the intrinsic nerves of the stomach will be discussed.

Citations

Citations to this article as recorded by  

• Impaired Cardiovagal Activity as a Link Between Hyperglycemia and Arterial Stiffness in Adults With Type 2 Diabetes Mellitus Among an Eastern Indian Population: A Cross-sectional Study
  Nibedita Priyadarsini, Devineni Likhitha, Madumathy Ramachandran, Kishore Kumar Behera
  Canadian Journal of Diabetes.2024; 48(3): 147.     CrossRef
• Diabetic visceral neuropathy of gastroparesis: Gastric mucosal innervation and clinical significance
  Ping‐Huei Tseng, Chi‐Chao Chao, Ya‐Yin Cheng, Chieh‐Chang Chen, Ping‐Hao Yang, Wei‐Kang Yang, Shao‐Wei Wu, Yen‐Wen Wu, Mei‐Fang Cheng, Wei‐Shiung Yang, Ming‐Shiang Wu, Sung‐Tsang Hsieh
  European Journal of Neurology.2022; 29(7): 2097.     CrossRef
• Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes
  Sasha Smith, Pasha Normahani, Tristan Lane, David Hohenschurz-Schmidt, Nick Oliver, Alun Huw Davies
  Life.2022; 12(7): 1074.     CrossRef
• Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning
  Antonio Crisafulli, Pasquale Pagliaro, Silvana Roberto, Lucia Cugusi, Giuseppe Mercuro, Antigone Lazou, Christophe Beauloye, Luc Bertrand, Derek J. Hausenloy, Manuela Aragno, Claudia Penna
  International Journal of Molecular Sciences.2020; 21(8): 2896.     CrossRef
• Distribution characteristics of sweat gland nerve fibres in normal humans identified by acetylcholinesterase histochemical staining
  Li Ling, Yongdan Liu, Yifei Sun, Yun Cai, Ye Jiang, Longjian Chen, Long He, Jinwei Xue
  Clinical Neurology and Neurosurgery.2020; 189: 105620.     CrossRef
• Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms
  Sakshi Tyagi, Nirmal Singh, Jasleen kaur Virdi, Amteshwar Singh Jaggi
  Journal of Physiology and Biochemistry.2019; 75(1): 19.     CrossRef
• Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus
  Chao Zhao, Chengfeng Yang, Sydney Tang Chi Wai, Yanbo Zhang, Maria P. Portillo, Paolo Paoli, Yijing Wu, Wai San Cheang, Bin Liu, Christian Carpéné, Jianbo Xiao, Hui Cao
  Critical Reviews in Food Science and Nutrition.2019; 59(6): 830.     CrossRef
• Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus
  Ioanna Eleftheriadou, George C. Drosos, Anastasios Tentolouris, Giorgios Konstantonis, Petros P. Sfikakis, Athanasios D. Protogerou, Nikolaos Tentolouris
  Journal of Human Hypertension.2018; 32(8-9): 531.     CrossRef
• Exposure to hypoglycemia and risk of stroke
  Logan Smith, Diya Chakraborty, Pallab Bhattacharya, Deepaneeta Sarmah, Sebastian Koch, Kunjan R. Dave
  Annals of the New York Academy of Sciences.2018; 1431(1): 25.     CrossRef
• Association between the risk of falls and osteoporotic fractures in patients with type 2 diabetes mellitus
  Maki Yokomoto-Umakoshi, Ippei Kanazawa, Shiori Kondo, Toshitsugu Sugimoto
  Endocrine Journal.2017; 64(7): 727.     CrossRef
• Diabetes‐induced mechanophysiological changes in the esophagus
  Jingbo Zhao, Hans Gregersen
  Annals of the New York Academy of Sciences.2016; 1380(1): 139.     CrossRef

Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes that is characterized by an early onset, autosomal dominant mode of inheritance and a primary defect in pancreatic β-cell function. MODY represents less than 2% of all diabetes cases and is commonly misdiagnosed as type 1 or type 2 diabetes mellitus. At least 13 MODY subtypes with distinct genetic etiologies have been identified to date. A correct genetic diagnosis is important as it often leads to personalized treatment for those with diabetes and enables predictive genetic testing for their asymptomatic relatives. Next-generation sequencing may provide an efficient method for screening mutations in this form of diabetes as well as identifying new MODY genes. In this review, I discuss a current update on MODY in the literatures and cover the studies that have been performed in Korea.

Citations

Citations to this article as recorded by  

• Alteraciones en el NeuroD1. Causa infrecuente de diabetes infantil y juvenil
  Ana Isabel García Muñoz, María José Ballester Herrera, Elena Martín Campagne, Enrique Palomo Atance
  Endocrinología, Diabetes y Nutrición.2023; 70(6): 438.     CrossRef
• An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cells
  Florian M. Hermann, Maya Friis Kjærgaard, Chenglei Tian, Ulf Tiemann, Abigail Jackson, Lars Rønn Olsen, Maria Kraft, Per-Ola Carlsson, Iina M. Elfving, Jarno L.T. Kettunen, Tiinamaija Tuomi, Ivana Novak, Henrik Semb
  Cell Stem Cell.2023; 30(1): 38.     CrossRef
• Prevalence of maturity-onset diabetes of the young in phenotypic type 2 diabetes in young adults: a nationwide, multi-center, cross-sectional survey in China
  Yan Chen, Jing Zhao, Xia Li, Zhiguo Xie, Gan Huang, Xiang Yan, Houde Zhou, Li Zheng, Tao Xu, Kaixin Zhou, Zhiguang Zhou
  Chinese Medical Journal.2023; 136(1): 56.     CrossRef
• In Silico Molecular Docking Studies of Phytocompounds From Coleus Amboinicus Against Glucokinase
  Soosai Marian Anthony Ammal, Sai Sudha, Durairaj Rajkumar, Adhithya Baskaran, Gunasekaran Krishnamoorthy , Madurai Kannan Anbumozhi
  Cureus.2023;[Epub]     CrossRef
• The Pathogenesis of Diabetes
  Huiqin Guo, Haili Wu, Zhuoyu Li
  International Journal of Molecular Sciences.2023; 24(8): 6978.     CrossRef
• Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
  Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
  International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
• A young‐onset type 2 diabetic Chinese girl with familial renal glycosuria caused by a novel mutation in SLC5A2: A case report
  Yuqing Qu, Limei Hao, Xianling Wang
  Journal of Diabetes.2023; 15(7): 622.     CrossRef
• Genetic and clinical characteristics of Turkish children with Maturity Onset Diabetes of the Young Type 2 (MODY2): A single center experience
  Özlem NALBANTOĞLU, Semra GÜRSOY, Tarık KIRKGÖZ, Filiz HAZAN, Behzat ÖZKAN
  Interdisciplinary Medical Journal.2023; 14(48): 51.     CrossRef
• Alterations in NeuroD1. Infrequent cause of infantile and juvenile diabetes
  Ana Isabel García Muñoz, María José Ballester Herrera, Elena Martín Campagne, Enrique Palomo Atance
  Endocrinología, Diabetes y Nutrición (English ed.).2023; 70(6): 438.     CrossRef
• Quantitative profiling and diagnostic potential of one-carbon and central metabolism pools in MODY2 and T1DM
  Jieying Liu, Ziyan Xie, Junling Fu, Miao Yu, Tong Wang, Cuijuan Qi, Peng Liu, Xiangyi Hui, Dongmei Wang, Lu Ding, Qian Zhang, Ting Xie, Xinhua Xiao
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Genetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions
  Hong-Yan Sun, Xiao-Yan Lin
  World Journal of Diabetes.2023; 14(12): 1738.     CrossRef
• Molecular and clinical assessment of maturity-onset diabetes of the young revealed low mutational rate in Moroccan families
  Said Trhanint, Laila Bouguenouch, Sana Abourazzak, Hanan El Ouahabi, Hanane Latrech, Salma Benyakhlef, Bahia Bennani, Ihssane El Bouchikhi, Fatima Zahra Moufid, Karim Ouldim, Lahsen El Ghadraoui, Nadia Maazouzi
  International Journal of Pediatrics and Adolescent Medicine.2022; 9(2): 98.     CrossRef
• Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study
  Carolina G. Downie, Sofia F. Dimos, Stephanie A. Bien, Yao Hu, Burcu F. Darst, Linda M. Polfus, Yujie Wang, Genevieve L. Wojcik, Ran Tao, Laura M. Raffield, Nicole D. Armstrong, Hannah G. Polikowsky, Jennifer E. Below, Adolfo Correa, Marguerite R. Irvin,
  Diabetologia.2022; 65(3): 477.     CrossRef
• When do we need to suspect maturity onset diabetes of the young in patients with type 2 diabetes mellitus?
  Özlem Üstay, Tugçe Apaydın, Onur Elbasan, Hamza Polat, Gizem Günhan, Ceyda Dinçer, Lamia Şeker, Esra Arslan Ateş, Ayşegül Yabacı, Ahmet lter Güney, Dilek Gogas Yavuz
  Archives of Endocrinology and Metabolism.2022;[Epub]     CrossRef
• Precision Diagnosis of Maturity-Onset Diabetes of the Young with Next-Generation Sequencing: Findings from the MODY-IST Study in Adult Patients
  Hulya Yilmaz Aydogan, Nurdan Gul, Deniz Kanca Demirci, Ummu Mutlu, Gizem Gulfidan, Kazim Yalcin Arga, Aclan Ozder, Ahmet Adil Camli, Yildiz Tutuncu, Oguz Ozturk, Canan Cacina, Feyza Darendeliler, Sukran Poyrazoglu, Ilhan Satman
  OMICS: A Journal of Integrative Biology.2022; 26(4): 218.     CrossRef
• Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review
  Qinying Zhao, Li Ding, Ying Yang, Jinhong Sun, Min Wang, Xin Li, Ming Liu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• ABCC8 ‐related maturity‐onset diabetes of the young: Clinical features and genetic analysis of one case
  Yun Zhou, Yan Sun, Chao Xu, Fan Liu, Yuye Gao, Caihong Liu, Yu Qiao, Jianmei Yang, Guimei Li
  Pediatric Diabetes.2022; 23(5): 588.     CrossRef
• Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12)
  Juyi Li, Xiufang Wang, Huihui Mao, Li Wen, Aiping Deng, Yarong Li, Hongmei Zhang, Chao Liu
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Early-onset diabetes involving three consecutive generations had different clinical features from age-matched type 2 diabetes without a family history in China
  Da-Wei Wang, Jing Yuan, Fang-yuan Yang, Hai-Yan Qiu, Jing Lu, Jin-Kui Yang
  Endocrine.2022; 78(1): 47.     CrossRef
• UDP-glucose, cereblon-dependent proinsulin degrader
  Jaeyong Cho, Atsushi Miyagawa, Kazuki Yamaguchi, Wakana Abe, Yoji Tsugawa, Hatsuo Yamamura, Takeshi Imai
  Scientific Reports.2022;[Epub]     CrossRef
• Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
  Hazar Younis, Se Eun Ha, Brian G. Jorgensen, Arushi Verma, Seungil Ro
  Journal of Personalized Medicine.2022; 12(11): 1762.     CrossRef
• Diagnosis and Treatment of Monogenic Forms of Diabetes Mellitus: Focus on Mody-Diabetes
  K. A. Aitbaev, I. T. Murkamilov, Zh. A. Murkamilova, V. V. Fomin, I. O Kudaibergenova, F. A. Yusupov
  The Russian Archives of Internal Medicine.2022; 12(6): 430.     CrossRef
• The Genetic Spectrum of Maturity-Onset Diabetes of the Young (MODY) in Qatar, a Population-Based Study
  Asma A. Elashi, Salman M. Toor, Ilhame Diboun, Yasser Al-Sarraj, Shahrad Taheri, Karsten Suhre, Abdul Badi Abou-Samra, Omar M. E. Albagha
  International Journal of Molecular Sciences.2022; 24(1): 130.     CrossRef
• MODY patients exhibit shorter telomere length than non‐diabetic subjects
  Andrea L. Millan, Sofía I. Trobo, Alejandro de Dios, Martina Cerrato García, María S. Pérez, Gloria E. Cerrone, Gustavo D. Frechtel, Ariel P. López
  Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
• Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells
  Chutima Charoensuk, Prapaporn Jungtrakoon Thamtarana, Chutima Chanprasert, Watip Tangjittipokin, Jun Shirakawa, Yu Togashi, Kazuki Orime, Pucharee Songprakhon, Chartchai Chaichana, Zuroida Abubakar, Paweena Ouying, Jatuporn Sujjitjoon, Alessandro Doria, N
  Molecular and Cellular Endocrinology.2021; 522: 111126.     CrossRef
• Late Diagnosis of Maturity-Onset Diabetes of the Young 12 With Catastrophic Consequences
  Nuno R Carreira, Catarina Gonçalves, Alexandra Wahnon, Sara Dâmaso, Joao Martins
  Cureus.2021;[Epub]     CrossRef
• Vanillic acid mitigates the impairments in glucose metabolism in HepG2 cells through BAD–GK interaction during hyperinsulinemia
  Mohan Sreelekshmi, Kozhiparambil Gopalan Raghu
  Journal of Biochemical and Molecular Toxicology.2021; 35(6): 1.     CrossRef
• Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis
  Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano, Angela Messina, Immacolata Speciale, Rosangela Artuso, Gaetano Bertino, Nicole Revencu, Xavier Stephénne, Cristina De Castro, Gert Matthijs, Rita Barone, Jaak Jaeken, Domenico Garozzo
  iScience.2021; 24(4): 102323.     CrossRef
• A Clinical Prediction Model to Distinguish Maturity-Onset Diabetes of the Young From Type 1 and Type 2 Diabetes in the Chinese Population
  Junling Fu, Fan Ping, Tong Wang, Yiwen Liu, Xiaojing Wang, Jie Yu, Mingqun Deng, Jieying Liu, Qian Zhang, Miao Yu, Ming Li, Yuxiu Li, Xinhua Xiao
  Endocrine Practice.2021; 27(8): 776.     CrossRef
• Combination of disease duration‐to‐age at diagnosis and hemoglobin A1c‐to‐serum C‐peptide reactivity ratios predicts patient response to glucose‐lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59)
  Azuma Kanatsuka, Yasunori Sato, Yoichiro Higashi, Yoshimasa Goto, Koichi Kawai, Hiroshi Maegawa
  Journal of Diabetes Investigation.2021; 12(11): 1967.     CrossRef
• Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients
  Dong-Hwa Lee, Soo-Heon Kwak, Hee Sue Park, Eu Jeong Ku, Hyun Jeong Jeon, Tae Keun Oh
  BMJ Open Diabetes Research & Care.2021; 9(1): e002217.     CrossRef
• Maturity Onset Diabetes of the Young—New Approaches for Disease Modelling
  Dawid Skoczek, Józef Dulak, Neli Kachamakova-Trojanowska
  International Journal of Molecular Sciences.2021; 22(14): 7553.     CrossRef
• Clinical and genetic features of maturity-onset diabetes of the young in pediatric patients: a 12-year monocentric experience
  Stefano Passanisi, Giuseppina Salzano, Bruno Bombaci, Fortunato Lombardo
  Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
• Maturity onset diabetes of the young
  Muhammad Yassir Yaqub Qureshi, Rabia Nawaz
  InnovAiT: Education and inspiration for general practice.2021; 14(11): 669.     CrossRef
• Diagnosis and Treatment of MODY: An Updated Mini Review
  Abegail Tshivhase, Tandi Matsha, Shanel Raghubeer
  Applied Sciences.2021; 11(20): 9436.     CrossRef
• NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report
  Lucia Brodosi, Bianca Baracco, Vilma Mantovani, Loris Pironi
  BMC Endocrine Disorders.2021;[Epub]     CrossRef
• Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
  Adnan Haider, Oksana Symczyk, Ayesha Hassan, Muhammad Atif Khan, Inderpreet Madahar, Dylan Holland, Wayne V. Moore
  Case Reports in Endocrinology.2021; 2021: 1.     CrossRef
• Gençlerin Erişkin Başlangıçlı Diyabeti (MODY) Sorumlu HNF4A, GCK ve HNF1 Gen Varyasyonlarının Dünya Genelinde Coğrafik Dağılımı
  Deniz KANCA DEMİRCİ, Nurdan GÜL, İlhan SATMAN, Oguz OZTURK, Hülya YILMAZ AYDOĞAN
  Haliç Üniversitesi Fen Bilimleri Dergisi.2021; 4(1): 41.     CrossRef
• Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL
  Wolfgang Landgraf, David R. Owens, Brian M. Frier, Mei Zhang, Geremia B. Bolli
  Diabetes, Obesity and Metabolism.2020; 22(3): 315.     CrossRef
• Molecular and clinical characteristics of monogenic diabetes mellitus in southern Chinese children with onset before 3 years of age
  Yunting Lin, Huiying Sheng, Tzer Hwu Ting, Aijing Xu, Xi Yin, Jing Cheng, Huifen Mei, Yongxian Shao, Chunhua Zeng, Wen Zhang, Min Rao, Li Liu, Xiuzhen Li
  BMJ Open Diabetes Research & Care.2020; 8(1): e001345.     CrossRef
• Maturity-onset diabetes of the young type 5 a MULTISYSTEMIC disease: a CASE report of a novel mutation in the HNF1B gene and literature review
  Juan Camilo Mateus, Carolina Rivera, Miguel O’Meara, Alex Valenzuela, Fernando Lizcano
  Clinical Diabetes and Endocrinology.2020;[Epub]     CrossRef
• Maturity-onset diabetes of the young: From a molecular basis perspective toward the clinical phenotype and proper management
  Sofia Castro Oliveira, João Sérgio Neves, Antonio Pérez, Davide Carvalho
  Endocrinología, Diabetes y Nutrición (English ed.).2020; 67(2): 137.     CrossRef
• Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel GCK, HNFA1 and HNFA4 Mutations
  Maria I. Alvelos, Catarina I. Gonçalves, Eduarda Coutinho, Joana T. Almeida, Margarida Bastos, Maria L. Sampaio, Miguel Melo, Sofia Martins, Isabel Dinis, Alice Mirante, Leonor Gomes, Joana Saraiva, Bernardo D. Pereira, Susana Gama-de-Sousa, Carolina More
  Journal of Clinical Medicine.2020; 9(1): 288.     CrossRef
• Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment
  Kyung Mi Jang
  Yeungnam University Journal of Medicine.2020; 37(1): 13.     CrossRef
• Maturity-onset diabetes of the young: From a molecular basis perspective toward the clinical phenotype and proper management
  Sofia Castro Oliveira, João Sérgio Neves, Antonio Pérez, Davide Carvalho
  Endocrinología, Diabetes y Nutrición.2020; 67(2): 137.     CrossRef
• A rare combination of MODY5 and duodenal atresia in a patient: a case report
  Tao Du, Nan Zeng, Xiaofang Wen, Peizhuang Zhu, Wangen Li
  BMC Medical Genetics.2020;[Epub]     CrossRef
• Molecular genetic study in a cohort of Iranian families suspected to maturity-onset diabetes of the young, reveals a recurrent mutation and a high-risk variant in the CEL gene
  Akram Sarmadi, Aliasgar Mohammadi, Fatemeh Tabatabaei, Zahra Nouri, MortezaHashemzadeh Chaleshtori, MohammadAmin Tabatabaiefar
  Advanced Biomedical Research.2020; 9(1): 25.     CrossRef
• Update on Monogenic Diabetes in Korea
  Ye Seul Yang, Soo Heon Kwak, Kyong Soo Park
  Diabetes & Metabolism Journal.2020; 44(5): 627.     CrossRef
• Pyruvate Kinase Controls Signal Strength in the Insulin Secretory Pathway
  Sophie L. Lewandowski, Rebecca L. Cardone, Hannah R. Foster, Thuong Ho, Evgeniy Potapenko, Chetan Poudel, Halena R. VanDeusen, Sophia M. Sdao, Tiago C. Alves, Xiaojian Zhao, Megan E. Capozzi, Arnaldo H. de Souza, Ishrat Jahan, Craig J. Thomas, Craig S. Nu
  Cell Metabolism.2020; 32(5): 736.     CrossRef
• Aberrant Sialylation in a Patient with a HNF1α Variant and Liver Adenomatosis
  Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano, Angela Messina, Immacolata Speciale, Rosangela Artuso, Sabrina Rita Giglio, Gaetano Bertino, Nicole Revencu, Xavier Stephénne, Cristina De Castro, Gert Matthijs, Rita Barone, Jaak Jaeken, Domenico
  SSRN Electronic Journal .2020;[Epub]     CrossRef
• Pathophysiology of diabetes: An overview
  Mujeeb Z Banday, Aga S Sameer, Saniya Nissar
  Avicenna Journal of Medicine.2020; 10(04): 174.     CrossRef
• Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing
  Hamza Dallali, Serena Pezzilli, Meriem Hechmi, Om Kalthoum Sallem, Sahar Elouej, Haifa Jmel, Yosra Ben Halima, Mariem Chargui, Mariem Gharbi, Luana Mercuri, Federica Alberico, Tommaso Mazza, Afaf Bahlous, Melika Ben Ahmed, Henda Jamoussi, Abdelmajid Abid,
  Acta Diabetologica.2019; 56(5): 515.     CrossRef
• MODY-Diabetes
  Sabina Baumgartner-Parzer
  Journal für Klinische Endokrinologie und Stoffwechsel.2019; 12(4): 165.     CrossRef
• Identification of a novel mutation site in maturity‑onset diabetes of the young in a Chinese family by whole‑exome sequencing
  Han Yu, Jingjin Liu, Xiaofei Li, Fang Miao, Yanlan Yang
  Molecular Medicine Reports.2019;[Epub]     CrossRef
• How can maturity-onset diabetes of the young be identified among more common diabetes subtypes?
  Jana Urbanova, Ludmila Brunerova, Jan Broz
  Wiener klinische Wochenschrift.2019; 131(17-18): 435.     CrossRef
• Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
  Junling Fu, Tong Wang, Jieying Liu, Xiaojing Wang, Qian Zhang, Ming Li, Xinhua Xiao
  Diabetes Therapy.2019; 10(4): 1381.     CrossRef
• First Report of Diabetes Phenotype due to a Loss-of-Function ABCC8 Mutation Previously Known to Cause Congenital Hyperinsulinism
  Theocharis Koufakis, Amalia Sertedaki, Elizabeth-Barbara Tatsi, Christina-Maria Trakatelli, Spyridon N. Karras, Eleni Manthou, Christina Kanaka-Gantenbein, Kalliopi Kotsa
  Case Reports in Genetics.2019; 2019: 1.     CrossRef
• Birthweight correlates with later metabolic abnormalities in Chinese patients with maturity-onset diabetes of the young type 2
  Junling Fu, Tong Wang, Jieying Liu, Xiaojing Wang, Ming Li, Xinhua Xiao
  Endocrine.2019; 65(1): 53.     CrossRef
• Molecular and cellular regulation of human glucokinase
  Shawn M. Sternisha, Brian G. Miller
  Archives of Biochemistry and Biophysics.2019; 663: 199.     CrossRef
• Genetic studies of multifactorial diseases in the concept of personalized medicine
  N. N. Belushkina, A. S. Chemezov, M. A. Paltsev
  Profilakticheskaya meditsina.2019; 22(3): 26.     CrossRef
• Epigenome-wide association study in peripheral white blood cells involving insulin resistance
  Ana Arpón, Fermín I. Milagro, Omar Ramos-Lopez, M. Luisa Mansego, José Luis Santos, José-Ignacio Riezu-Boj, J. Alfredo Martínez
  Scientific Reports.2019;[Epub]     CrossRef
• Maturity Onset Diabetes of the Young: A Rare Monogenic Form of Diabetes
  Kallarackal M
  International Journal of Clinical Endocrinology and Metabolism.2019; : 006.     CrossRef
• Hidden MODY—Looking for a Needle in a Haystack
  Jana Urbanová, Ludmila Brunerová, Jan Brož
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Fifteen-minute consultation: Monogenic forms of diabetes with onset after age 6 months
  Emma M Dyer, Rakesh Amin
  Archives of disease in childhood - Education & practice edition.2018; 103(2): 58.     CrossRef
• Aspectos clínicos y diagnósticos de la diabetes infantil
  M. Louvigné, A. Decrequy, A. Donzeau, N. Bouhours-Nouet, R. Coutant
  EMC - Pediatría.2018; 53(1): 1.     CrossRef
• Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives
  Parveena Firdous, Kamran Nissar, Sajad Ali, Bashir Ahmad Ganai, Uzma Shabir, Toyeeba Hassan, Shariq Rashid Masoodi
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Applications of mesoporous silica in biosensing and controlled release of insulin
  Maria Sönmez, Denisa Ficai, Anton Ficai, Laurentia Alexandrescu, Mihai Georgescu, Roxana Trusca, Dana Gurau, Mihail Aurel Titu, Ecaterina Andronescu
  International Journal of Pharmaceutics.2018; 549(1-2): 179.     CrossRef
• Novel deletion mutation in the glucokinase gene from a Korean man with GCK-MODY phenotype and situs inversus
  Yun Kyung Cho, Eun-Hee Cho, Hoon Sung Choi, Sang-Wook Kim
  Diabetes Research and Clinical Practice.2018; 143: 263.     CrossRef
• Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations
  S. Ben Khelifa, R. Martinez, A. Dandana, I. Khochtali, S. Ferchichi, L. Castaño
  Gene.2018; 651: 44.     CrossRef
• Pregnancy Complicated by Maternal MODY 3 and Paternal MODY 2 Diabetes and Subsequent Rapidly Falling Insulin Requirement
  Anastasia Mikuscheva, Adel Mekhail, Benjamin J. Wheeler
  Case Reports in Obstetrics and Gynecology.2018; 2018: 1.     CrossRef
• Mechanistic Origins of Enzyme Activation in Human Glucokinase Variants Associated with Congenital Hyperinsulinism
  Shawn M. Sternisha, Peilu Liu, Alan G. Marshall, Brian G. Miller
  Biochemistry.2018; 57(10): 1632.     CrossRef
• Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
  Xiuzhen Li, Tzer Hwu Ting, Huiying Sheng, Cui Li Liang, Yongxian Shao, Minyan Jiang, Aijing Xu, Yunting Lin, Li Liu
  BMC Pediatrics.2018;[Epub]     CrossRef
• Pathway-induced allelic spectra of diseases in the presence of strong genetic effects
  George Kanoungi, Michael Nothnagel
  Human Genetics.2018; 137(3): 215.     CrossRef
• Identification of Maturity-Onset Diabetes of the Young Caused by Glucokinase Mutations Detected Using Whole-Exome Sequencing
  Eun-Hee Cho, Jae Woong Min, Sun Shim Choi, Hoon Sung Choi, Sang-Wook Kim
  Endocrinology and Metabolism.2017; 32(2): 296.     CrossRef
• The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes
  J.V. Sagen, L. Bjørkhaug, B.I. Haukanes, L. Grevle, J. Molnes, B.G. Nedrebø, O. Søvik, P.R. Njølstad, S. Johansson, A. Molven
  Diabetes Research and Clinical Practice.2017; 133: 142.     CrossRef
• Variants in MODY genes associated with maternal lipids profiles in second trimester of pregnancy
  Xiaojing Wang, Wei Li, Liangkun Ma, Fan Ping, Juntao Liu, Xueyan Wu, Jiangfeng Mao, Xi Wang, Min Nie
  The Journal of Gene Medicine.2017; 19(6-7): e2962.     CrossRef
• Genotype-Phenotype Correlation in a MODY 2 Family: An Under-Diagnosed Disease
  Maria Chiara Fabiano, Antonella Verrienti, Antonella Carbone, Marialuisa Sponziello, Pasquale Bellitti, Rocco Bruno
  Journal of Diabetes Mellitus.2016; 06(04): 263.     CrossRef
• Revisiting the Polygenic Additive Liability Model through the Example of Diabetes Mellitus
  Emmanuelle Génin, Françoise Clerget-Darpoux
  Human Heredity.2015; 80(4): 171.     CrossRef

Citations

Citations to this article as recorded by  

• Insulin-induced skin lipohypertrophies: A neglected cause of hypoglycemia in dialysed individuals with diabetes
  Sandro Gentile, Ersilia Satta, Felice Strollo, Giuseppina Guarino, Carmine Romano, Teresa Della Corte, Carmelo Alfarone
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(4): 102145.     CrossRef
• Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
  Sandro Gentile, Felice Strollo, Ersilia Satta, Teresa Della Corte, Carmine Romano, Giuseppina Guarino
  Diabetes Therapy.2019; 10(4): 1423.     CrossRef
• Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes
  Soyeon Yoo, Eun-Jin Yang, Sang Ah Lee, Gwanpyo Koh
  Endocrine Research.2018; 43(1): 47.     CrossRef
• Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist
  Ying Li, Xuemin Zheng, Xiulin Yi, Changxiao Liu, Dexin Kong, Jianning Zhang, Min Gong
  The FASEB Journal.2017; 31(6): 2603.     CrossRef
• Hypoglycemia and Health Costs
  Yong-ho Lee, Gyuri Kim, Eun Seok Kang
  The Journal of Korean Diabetes.2016; 17(1): 11.     CrossRef

Citations

Citations to this article as recorded by  

• Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
  Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
  Advances in Therapy.2024; 41(5): 1967.     CrossRef
• Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era
  Abhishek Shrivastava, Jothydev Kesavadev, Viswanathan Mohan, Banshi Saboo, Dina Shrestha, Anuj Maheshwari, Brij Mohan Makkar, Kirtikumar D. Modi, Ashok Kumar Das
  Current Diabetes Reviews.2023;[Epub]     CrossRef
• Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China
  Minyuan Chen, Puhong Zhang, Yang Zhao, Nadila Duolikun, Linong Ji
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 3375.     CrossRef
• Therapeutic Effect of Quadruple Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Who Have Insulin Limitations
  Won Sang Yoo, Do Hee Kim, Hee Jin Kim, Hyun Kyung Chung
  The Journal of Korean Diabetes.2019; 20(2): 117.     CrossRef
• Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review
  Takahisa Hirose, Ching-Chu Chen, Kyu Jeung Ahn, Jacek Kiljański
  Diabetes Therapy.2019; 10(3): 805.     CrossRef
• Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors
  Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang
  Diabetes Care.2019; 42(11): 2057.     CrossRef
• Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  The Korean Journal of Internal Medicine.2017; 32(6): 967.     CrossRef
• Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  Diabetes & Metabolism Journal.2017; 41(5): 367.     CrossRef
• Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study)
  Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee, Byung-Wan Lee
  Journal of Diabetes Research.2017; 2017: 1.     CrossRef
• Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea
  Sung Hee Choi, Tae Jung Oh, Hak Chul Jang
  Diabetes & Metabolism Journal.2017; 41(3): 170.     CrossRef
• Instauration d’une insulinothérapie chez le patient diabétique de type 2 en médecine générale : Comparaison de l’étude belge InsuStar avec quelques études françaises et internationales
  A.-J. Scheen
  Médecine des Maladies Métaboliques.2016; 10(4): 334.     CrossRef

Citations

Citations to this article as recorded by  

• A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
  Eugene Han, Hye Sun Park, Obin Kwon, Eun Yeong Choe, Hye Jin Wang, Yong-ho Lee, Sang-Hak Lee, Chul Hoon Kim, Lee-Kyung Kim, Soo Heon Kwak, Kyong Soo Park, Chul Sik Kim, Eun Seok Kang
  Medicine.2016; 95(44): e5155.     CrossRef

Citations

Citations to this article as recorded by  

• Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes
  Ninoschka C. D’Souza, Julian A. Aiken, Emily G. Hoffman, Sara C. Atherley, Sabrina Champsi, Nadia Aleali, Dorsa Shakeri, Maya El-Zahed, Nicky Akbarian, Mehran Nejad-Mansouri, Parinaz Z. Bavani, Richard L. Liggins, Owen Chan, Michael C. Riddell
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
  Jenny Dimakos, Ying Cui, Robert W. Platt, Christel Renoux, Kristian B. Filion, Antonios Douros
  Diabetes Care.2023; 46(2): 377.     CrossRef
• Evaluating the effect of Roxadustat on ventricular repolarization in patients undergoing peritoneal dialysis
  Yangyang Zhang, Liang Zhang, Pengcheng Ge, Ruyi Xu, Zhen Ye
  European Journal of Medical Research.2023;[Epub]     CrossRef
• Diabetic Neuropathy and Risk of Cardiovascular Disease
  Jae-Seung Yun
  The Journal of Korean Diabetes.2022; 23(4): 245.     CrossRef
• Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention
  Huda Y. Almomani, Carlos Rodriguez Pascual, Sayer I. Al-Azzam, Keivan Ahmadi
  Research in Social and Administrative Pharmacy.2021; 17(5): 885.     CrossRef
• Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes
  W. David Strain, Su Down, Pam Brown, Amar Puttanna, Alan Sinclair
  Diabetes Therapy.2021; 12(5): 1227.     CrossRef
• Management of hypoglycemia in older adults with type 2 diabetes
  Jeffrey Freeman
  Postgraduate Medicine.2019; 131(4): 241.     CrossRef
• Use of stellate ganglion block for treatment of recurrent syncope followed by chest pain
  Young-ung Kim, Yong-joon Shin, Young Woo Cho
  Yeungnam University Journal of Medicine.2018; 35(1): 104.     CrossRef
• Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction
  Sridharan Raghavan, Wenhui G. Liu, P. Michael Ho, Mary E. Plomondon, Anna E. Barón, Liron Caplan, Karen E. Joynt Maddox, David Magid, David R. Saxon, Corrine I. Voils, Steven M. Bradley, Thomas M. Maddox
  Journal of Diabetes and its Complications.2018; 32(5): 480.     CrossRef
• Depth and combined infection is important predictor of lower extremity amputations in hospitalized diabetic foot ulcer patients
  Eun-Gyo Jeong, Sung Shim Cho, Sang-Hoon Lee, Kang-Min Lee, Seo-Kyung Woo, Yoongoo Kang, Jae-Seung Yun, Seon-Ah Cha, Yoon-Jung Kim, Yu-Bae Ahn, Seung-Hyun Ko, Jung-Min Lee
  The Korean Journal of Internal Medicine.2018; 33(5): 952.     CrossRef
• Time- and frequency-domain measures of heart rate variability predict cardiovascular outcome in patients with type 2 diabetes
  Seon-Ah Cha, Yong-Moon Park, Jae-Seung Yun, Seung-Hwan Lee, Yu-Bae Ahn, Sung-Rae Kim, Seung-Hyun Ko
  Diabetes Research and Clinical Practice.2018; 143: 159.     CrossRef
• Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
  Alexandra K. Lee, Clare J. Lee, Elbert S. Huang, A. Richey Sharrett, Josef Coresh, Elizabeth Selvin
  Diabetes Care.2017; 40(12): 1661.     CrossRef
• Early inner retinal thinning and cardiovascular autonomic dysfunction in type 2 diabetes
  Jin A. Choi, Hyo Won Kim, Jin-Woo Kwon, Yun-sub Shim, Dong Hyun Jee, Jae-Seung Yun, Yu-Bae Ahn, Chan Kee Park, Seung-Hyun Ko, Patrice E. Fort
  PLOS ONE.2017; 12(3): e0174377.     CrossRef
• Cardiovascular Autonomic Dysfunction Predicts Diabetic Foot Ulcers in Patients With Type 2 Diabetes Without Diabetic Polyneuropathy
  Jae-Seung Yun, Seon-Ah Cha, Tae-Seok Lim, Eun-Young Lee, Ki-Ho Song, Yu-Bae Ahn, Ki-Dong Yoo, Joon-Sung Kim, Yong-Moon Park, Seung-Hyun Ko
  Medicine.2016; 95(12): e3128.     CrossRef
• Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea
  Jae-Seung Yun, Tae-Seok Lim, Seon-Ah Cha, Yu-Bae Ahn, Ki-Ho Song, Jin A Choi, Jinwoo Kwon, Donghyun Jee, Yang Kyung Cho, Yong-Moon Park, Seung-Hyun Ko
  Diabetes & Metabolism Journal.2016; 40(6): 482.     CrossRef
• Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes
  Seon-Ah Cha, Jae-Seung Yun, Tae-Seok Lim, Kyoungil Min, Ki-Ho Song, Ki-Dong Yoo, Yong-Moon Park, Yu-Bae Ahn, Seung-Hyun Ko, James M Wright
  PLOS ONE.2016; 11(10): e0164807.     CrossRef
• Meta-analysis: Association between hypoglycaemia and serious adverse events in older patients
  Katharina Mattishent, Yoon Kong Loke
  Journal of Diabetes and its Complications.2016; 30(5): 811.     CrossRef
• Letter: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
  Mi-Kyung Kim
  Diabetes & Metabolism Journal.2016; 40(1): 83.     CrossRef
• Response: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
  Jae-Seung Yun, Yu-Bae Ahn
  Diabetes & Metabolism Journal.2016; 40(1): 85.     CrossRef
• Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus
  J.‐S. Yun, Y.‐B. Ahn, K.‐H. Song, K.‐D. Yoo, Y.‐M. Park, H.‐W. Kim, S.‐H. Ko
  Diabetic Medicine.2016; 33(5): 639.     CrossRef
• Severe Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes
  Hyeong Kyu Park
  Diabetes & Metabolism Journal.2015; 39(6): 478.     CrossRef

Citations

Citations to this article as recorded by  

• Predelivery HbA1c levels and their relationship with adverse perinatal outcomes in women with normal 75-g OGTT
  Xiaoxia Tang, Jin Wei, Zifeng Jiang, Shaohua Wu
  Archives of Gynecology and Obstetrics.2023;[Epub]     CrossRef
• The diagnostic value of glycosylated hemoglobin for gestational diabetes mellitus in Asian populations: A systematic review and meta‐analysis
  Jiani Zhang, Fan Zhou, Tingting Xu, Jinfeng Xu, Yaqian Li, Li Lin, Qi Cao, Xiaodong Wang
  Journal of Obstetrics and Gynaecology Research.2022; 48(4): 902.     CrossRef
• The role of first-trimester HbA1c in the early detection of gestational diabetes
  Mehrnaz Valadan, Zeinab Bahramnezhad, Fatemeh Golshahi, Elham Feizabad
  BMC Pregnancy and Childbirth.2022;[Epub]     CrossRef
• Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring
  Martina Gáborová, Viera Doničová, Ivana Bačová, Mária Pallayová, Martin Bona, Igor Peregrim, Soňa Grešová, Judita Štimmelová, Barbora Dzugasová, Lenka Šalamonová Blichová, Viliam Donič
  International Journal of Environmental Research and Public Health.2021; 18(7): 3402.     CrossRef
• A Review on Research Progress in the Application of Glycosylated Hemoglobin and Glycated Albumin in the Screening and Monitoring of Gestational Diabetes
  Xinyan Liu, Na Wu, Abdulrahman Al-Mureish
  International Journal of General Medicine.2021; Volume 14: 1155.     CrossRef
• Evaluation of the Combination of HbA1C with Hematocrit for Early Screening of Gestational Diabetes Mellitus
  Ali Reza Norouzi, Mahsa Siavashi, Fatemeh Norouzi, Maryam Talayeh, Somayyeh Noei Teymoordash
  Journal of Obstetrics, Gynecology and Cancer Research.2021; 6(4): 217.     CrossRef
• The accuracy of haemoglobin A1c as a screening and diagnostic test for gestational diabetes: a systematic review and meta-analysis of test accuracy studies
  Chiamaka Esther Amaefule, Archana Sasitharan, Princee Kalra, Stamatina Iliodromoti, Mohammed S.B. Huda, Ewelina Rogozinska, Javier Zamora, Shakila Thangaratinam
  Current Opinion in Obstetrics & Gynecology.2020; 32(5): 322.     CrossRef
• Downregulation of microRNA-873 attenuates insulin resistance and myocardial injury in rats with gestational diabetes mellitus by upregulating IGFBP2
  Na Han, Hai-Yan Fang, Jie-Xuan Jiang, Qian Xu
  American Journal of Physiology-Endocrinology and Metabolism.2020; 318(5): E723.     CrossRef
• Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus
  Duria A. Rayis, Abdel B. A. Ahmed, Manal E. Sharif, Amir ElSouli, Ishag Adam
  Journal of Clinical Laboratory Analysis.2020;[Epub]     CrossRef
• Mid‐trimester glycosylated hemoglobin levels (HbA1c) and its correlation with oral glucose tolerance test (World Health Organization 1999)
  Devanshi Dubey, Shipra Kunwar, Uma Gupta
  Journal of Obstetrics and Gynaecology Research.2019; 45(4): 817.     CrossRef
• The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus
  Kui Wu, Yan Cheng, Tingting Li, Ziwen Ma, Junxiu Liu, Qingying Zhang, Haidong Cheng
  Diabetology & Metabolic Syndrome.2018;[Epub]     CrossRef
• The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
  Seyoung Kwon, Youngak Na
  The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
• Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c)
  Fahmy W Hanna, Christopher J Duff, Ann Shelley-Hitchen, Ellen Hodgson, Anthony A Fryer
  Clinical Medicine.2017; 17(2): 108.     CrossRef
• Utility of Glycated Haemoglobin in Gestational Diabetes Mellitus: Present and Future
  Rajesh Rajput, Deepak Jain
  EMJ Diabetes.2016; : 84.     CrossRef

Citations

Citations to this article as recorded by  

• Association between Transcription Factor 7-Like 2 Gene Polymorphisms rs7903146 and rs12255372 with the Risk of Diabetic Nephropathy among South Indian Population
  Balaji Ramanathan, Kumaravel Velayutham
  Chronicle of Diabetes Research and Practice.2024; 3(1): 8.     CrossRef
• Association between TCF7L2 polymorphism and type 2 diabetes mellitus susceptibility: a case–control study among the Bangladeshi population
  Asma Salauddin, Kallyan Chakma, Md. Mahbub Hasan, Farhana Akter, Nowshad Asgar Chowdhury, Sumon Rahman Chowdhury, Adnan Mannan
  Molecular Biology Reports.2023; 50(1): 609.     CrossRef
• Role of rs7903146 polymorphism and adropin serum level in patients with diabetes mellitus; a case–control study from Isfahan, Iran
  Abbas-Ali Palizban, Abdol-Hamid Yazdani, Hamidreza Jahanbani-Ardakani
  Archives of Physiology and Biochemistry.2022; 128(2): 378.     CrossRef
• PPARɣ2, aldose reductase, and TCF7L2 gene polymorphisms: relation to diabetes mellitus
  Hadeel Ahmed Shawki, Ekbal M. Abo-hashem, Magdy M. Youssef, Maha Shahin, Rasha Elzehery
  Journal of Diabetes & Metabolic Disorders.2022; 21(1): 241.     CrossRef
• Case-control study on the association between the GATA2 gene and premature myocardial infarction in the Iranian population
  Peyman Izadpanah, Ehsan Khabbzi, Saiedeh Erfanian, Simin Jafaripour, Mohammad Shojaie
  Herz.2021; 46(1): 71.     CrossRef
• Polymorphic genetic markers and how they are associated with clinical and metabolic indicators of type 2 diabetes mellitus in the Kazakh population
  Valeriy V. Benberin, Tamara A. Vochshenkova, Gulshara Zh. Abildinova, Anna V. Borovikova, Almagul A. Nagimtayeva
  Journal of Diabetes & Metabolic Disorders.2021; 20(1): 131.     CrossRef
• The role of transcription factor 7‐like 2 in metabolic disorders
  Zhensheng Zhang, Li Xu, Xiao Xu
  Obesity Reviews.2021;[Epub]     CrossRef
• Association of transcription factor 7-like 2 (rs7903146) gene polymorphism with diabetic retinopathy
  Hadeel Ahmed Shawki, Ekbal M.Abo-Hashem, Magdy M. Youssef, Maha Shahin, Rasha Elzehery
  Ophthalmic Genetics.2020; 41(5): 420.     CrossRef
• Association of SLC30A8, CDKAL1, TCF7L2 and HHEX Gene Polymorphisms with Type 2 Diabetes in the Population of North East India
  A. Bhowmick, P. Sarkar, M. P. Baruah, D. Bodhini, V. Radha, V. Mohan, S. Banu
  Cytology and Genetics.2020; 54(2): 165.     CrossRef
• Transcription Factor 7-Like-2 (TCF7L2) rs7903146 (C/T) Polymorphism in Patients with Type 2 Diabetes Mellitus
  Ahmed Mohamed Bahaaeldin, Arig Aly Seif, Amira Ibrahim Hamed, Walaa Ahmed Yousry Kabiel
  Dubai Diabetes and Endocrinology Journal.2020; 26(3): 112.     CrossRef
• The antileukemic effects of saffron (Crocus sativus L.) and its related molecular targets: A mini review
  Maliheh Moradzadeh, Mohamad Reza Kalani, Amir Avan
  Journal of Cellular Biochemistry.2019; 120(4): 4732.     CrossRef
• Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with type 2 diabetes mellitus in Chinese Korean ethnicity population
  Kui-Chen Zhou, Hong-Wei Liu, Chen Wang, Yan-Jun Fu, Feng Jin
  Medicine.2019; 98(5): e14288.     CrossRef
• Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism
  Gisela Geoghegan, Judith Simcox, Marcus M. Seldin, Timothy J. Parnell, Chris Stubben, Steven Just, Lori Begaye, Aldons J. Lusis, Claudio J. Villanueva
  Molecular Metabolism.2019; 24: 44.     CrossRef
• Association study of the rs46522 polymorphism in UBE2Z and rs7903146 polymorphism in TCF7L2 gene with T2DM in Arab population of Khuzestan province: case-control study
  Sana Shafidelpour, Ali Mohammad Foroughmand, Merhrnoosh Zakerkish, Mahdi Pourmahdi Borujeni
  Medical Journal of Tabriz University of Medical Sciences and Health Services.2019; 41(6): 59.     CrossRef
• Transcription factor 7-like 2 single nucleotide polymorphisms are associated with lipid profile in the Balinese
  Sukma Oktavianthi, Made R. Saraswati, Ketut Suastika, Pande Dwipayana, Asri Sulfianti, Rahma F. Hayati, Hidayat Trimarsanto, Clarissa A. Febinia, Herawati Sudoyo, Safarina G. Malik
  Molecular Biology Reports.2018; 45(5): 1135.     CrossRef
• Association of TCF7L2 mutation and atypical diabetes in a Uruguayan population
  Carolina Beloso, Jorge Souto, Matias Fábregat, Gerardo Romanelli, Gerardo Javiel, Adriana Mimbacas
  World Journal of Diabetes.2018; 9(9): 157.     CrossRef
• Associations of TCF7L2 gene polymorphisms with the risk of diabetic nephropathy
  Yan Zhuang, Fukun Niu, Defeng Liu, Juanjuan Sun, Xiaowei Zhang, Jian Zhang, Shuxia Guo
  Medicine.2018; 97(40): e8388.     CrossRef

Citations

Citations to this article as recorded by  

• Metformin Induces Lipogenesis and Apoptosis in H4IIE Hepatocellular Carcinoma Cells
  Deokbae Park, Sookyoung Lee, Hyejin Boo
  Development & Reproduction.2023; 27(2): 77.     CrossRef
• Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies
  Alaa Elmetwalli, Neamat H. Kamosh, Rania El Safty, Amany I. Youssef, Mohammed M. Salama, Khaled M. Abd El-Razek, Tarek El-Sewedy
  Medical Oncology.2023;[Epub]     CrossRef
• Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer
  Hao Wu, Dianlun Qian, Xiangfeng Bai, Shibo Sun, Jayaprakash Narayana Kolla
  Journal of Oncology.2022; 2022: 1.     CrossRef
• The effects of metformin on autophagy
  Guangli Lu, Zhen Wu, Jia Shang, Zhenxing Xie, Chaoran Chen, Chuning zhang
  Biomedicine & Pharmacotherapy.2021; 137: 111286.     CrossRef
• Protective Effect of Metformin against Hydrogen Peroxide-Induced Oxidative Damage in Human Retinal Pigment Epithelial (RPE) Cells by Enhancing Autophagy through Activation of AMPK Pathway
  Xia Zhao, Linlin Liu, Yizhou Jiang, Marta Silva, Xuechu Zhen, Wenhua Zheng
  Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef

• Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells

  
  Chun Gao, Long Fang, Hui Zhang, Wei-Shuo Zhang, Xiao-Ou Li, Shi-Yu Du
  Cancer Management and Research.2020; Volume 12: 5803.     CrossRef
• Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα
  Min Yan, Huan Qi, Tian Xia, Xinjie Zhao, Wen Wang, Zhichao Wang, Chang Lu, Zhen Ning, Huan Chen, Tongming Li, Dinesh Singh Tekcham, Xiumei Liu, Jing Liu, Di Chen, Xiaolong Liu, Guowang Xu, Hai-long Piao
  Metabolism.2019; 91: 18.     CrossRef
• Metformin Induces Oxidative Stress-Mediated Apoptosis without the Blockade of Glycolysis in H4IIE Hepatocellular Carcinoma Cells
  Deokbae Park
  Biological and Pharmaceutical Bulletin.2019; 42(12): 2002.     CrossRef
• Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation
  Cui Zhai, Wenhua Shi, Wei Feng, Yanting Zhu, Jian Wang, Shaojun Li, Xin Yan, Qingting Wang, Qianqian Zhang, Limin Chai, Cong Li, Pengtao Liu, Manxiang Li
  Life Sciences.2018; 208: 87.     CrossRef
• Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells
  Aneta Rogalska, Barbara Bukowska, Agnieszka Marczak
  Toxicology in Vitro.2018; 47: 48.     CrossRef
• Quantitative assessment of cell fate decision between autophagy and apoptosis
  Bing Liu, Zoltán N. Oltvai, Hülya Bayır, Gary A. Silverman, Stephen C. Pak, David H. Perlmutter, Ivet Bahar
  Scientific Reports.2017;[Epub]     CrossRef
• Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
  Shujuan Ma, Yixiang Zheng, Yanni Xiao, Pengcheng Zhou, Hongzhuan Tan
  Medicine.2017; 96(19): e6888.     CrossRef
• ROS Production and ERK Activity Are Involved in the Effects of d-β-Hydroxybutyrate and Metformin in a Glucose Deficient Condition
  Santosh Lamichhane, Tonking Bastola, Ramesh Pariyar, Eun-Sol Lee, Ho-Sub Lee, Dae Lee, Jungwon Seo
  International Journal of Molecular Sciences.2017; 18(3): 674.     CrossRef
• Metformin represses glucose starvation induced autophagic response in microvascular endothelial cells and promotes cell death
  Samson Mathews Samuel, Suparna Ghosh, Yasser Majeed, Gnanapragasam Arunachalam, Mohamed M. Emara, Hong Ding, Chris R. Triggle
  Biochemical Pharmacology.2017; 132: 118.     CrossRef
• NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action
  Jeongho Kim, Hye-Yeon Lee, Jheesoo Ahn, Moonjung Hyun, Inhwan Lee, Kyung-Jin Min, Young-Jai You
  Journal of Biological Chemistry.2016; 291(35): 18591.     CrossRef
• Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
  Archana Bhaw-Luximon, Dhanjay Jhurry
  Journal of Cancer Research and Clinical Oncology.2016; 142(10): 2159.     CrossRef
• Metformina: stary lek w nowej aplikacji
  Anna Dmoszyńska, Monika Podhorecka, Krzysztof Giannopoulos
  Acta Haematologica Polonica.2016; 47(2): 139.     CrossRef